ASH 2017: Janssen to Present 40 Abstracts, Including 8 Oral Presentations, with New Data on DARZALEX ® (daratumumab), IMBRUVICA® (ibrutinib) and Other Compounds from Robust Portfolio

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals